VAERS reports by lot

Pfizer COVID-19 lot FF3590: VAERS reports

25 VAERS reports list lot FF3590 as a Pfizer COVID-19 vaccine, received between 2021-10-09 and 2023-08-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
28%
Marked serious
2
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2122%
Neurological1415%
Cardiac / Cardiovascular1213%
Gastrointestinal1112%
Respiratory89%
Musculoskeletal89%
Dermatological (non-injection-site)89%
Allergic / Anaphylactic77%
Injection-site / Local reaction22%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Arizona4
Washington3
Virginia3
New York2
Delaware1
Arkansas1
Tennessee1
Texas1
Missouri1
Wisconsin1
Florida1
Massachusetts1

Reports by month received

2021-1010
2021-114
2022-021
2022-032
2022-043
2022-091
2022-121
2023-011
2023-051
2023-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.